ArticleAnnals of medicine and surgery (2012)2026
Dietary fatty acid intake and the risk of pancreatic cancer: a dose-response meta-analysis of observational studies.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of fatty acids on pancreatic cancer (PC) risk remains contentious, prompting evaluation through current observational evidence. This systematic review and dose-response meta-analysis of observational studies aim to examine the association between dietary polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs), saturated fatty acids (SFAs), trans fatty acids (TFAs), and the risk of PC. Methods: We systematically searched PubMed, Scopus, Cochrane, and Web of Science until December 2024. We included cohort and case-control studies that reported risk ratios (RRs), odds ratios (ORs), or hazard ratios (HRs) with 95% confidence intervals (CIs). The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of the included studies. Results: Overall, 26 observational studies (15 case-control and 11 cohort) showed no significant associations between TFA, MUFA, PUFA, or SFA intake and PC risk. However, case-control studies indicated a significant positive association for SFA intake (OR: 1.43; 95% CI: 1.02-1.99) and an inverse association for PUFA intake (OR: 0.74; 95% CI: 0.59-0.94). No significant relationship was found for TFA or MUFA intake in case-control studies. Stratification by study design was conducted to address differences in bias, such as recall bias in case-control studies and longer follow-up periods in cohort studies. Conclusion: Our findings suggest that modifying dietary fatty acid intake may contribute to PC prevention. These results highlight the need for further research to confirm these associations, explore underlying mechanisms, and examine the impact of dietary patterns and fatty acid sources on PC risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.